The pharmacodynamic effects of amikacin, imipenem, ofloxacin, rifampin, and vancomycin were studied on the slime-producing, oxacillin-resistant strain Staphylococcus epidermidis ATCC 35984 growing in Mueller Hinton broth or, in order to inhibit growth, incubated in phosphate-buffered saline. The investigated parameters were postantibiotic effect (PAE) and control-related effective regrowth time (CERT), which were determined by bioluminescence assay of bacterial ATP. PAE describes the delayed regrowth after drug removal, and CERT describes the combined effects of initial change in bacterial density during antibiotic exposure and delayed regrowth after drug removal. In growing cultures, PAE and CERT were drug concentration dependent for all antibiotics. The length of the PAE and CERT in the growing cultures were as follows: ofloxacin > rifampin > amikacin > vancomycin > imipenem. Imipenem combined with amikacin and vancomycin, respectively, induced a synergistic effect against growing cultures. In nongrowing cultures rifampin was the only drug that induced strong concentration-dependent effects. The combination of drugs induced no synergistic effects against nongrowing bacteria.
The increasing use of intravascular catheters, endoprostheses, and other foreign body material has resulted in accelerated problems with the formation of bacterial biofilms on the surfaces of these devices, and often these biofilms consist of coagulase-negative staphylococci. Bacteria in biofilms, as well as bacteria in abscesses and bacteria that cause endocarditis, are difficult to eradicate with antibiotics, possibly due to a decreased growth rate (4) . Antibiotic effects on nongrowing bacteria cannot be investigated by conventional susceptibility tests. However, time-kill studies (17) or minimal bactericidal concentration determinations (7) have been used. In this study we investigated the postantibiotic effect (PAE), which is the delayed regrowth after a brief exposure to drug. Studies of PAE may be of use in determining antibiotic dosing schedules, and PAEs have been demonstrated for a number of drugs against staphylococci (5) . Since determination of PAE requires repeated quantitation of bacterial numbers and the viable count method is very laborious, other methods for bacterial quantitation have been used (3, (9) (10) (11) 13) . However, the PAE results obtained by these methods differ, in particular for gram-negative bacteria (3, 9, 10, 13) . To circumvent these methodological differences, we have used the control-related effective regrowth time (CERT), which is independent of the method used for bacterial quantitation (9) . CERT is the time needed for the antibiotic-exposed culture to resume logarithmic growth and to return to the preexposure inoculum compared to the corresponding time for the control culture.
The aim of this study was to compare antibiotic effects against cultures of growing and nongrowing Staphylococcus epidermidis ATCC 35984 exposed to amikacin, imipenem, ofloxacin, rifampin, and vancomycin and combinations of these drugs by using PAE and CERT.
(This study was presented in part as a poster at the 35th (Fig. 1) . A total of 50 ml of the PBS culture was then incubated at 37ЊC for 24 h in a 500-ml Erlenmeyer flask. The MHB culture and the PBS culture were added in 1-ml aliquots to tubes containing 10 l of each antibiotic solution, giving the final concentrations indicated in Table 1 .
Determination of MIC. Serial twofold dilutions of antibiotics were prepared in sterile water. From these dilutions 10-l samples were added to series of test tubes. Bacteria from overnight cultures were diluted to reach a concentration of approximately 10 5 CFU/ml, and 1 ml of these cultures was then added to the test tubes, which were then incubated at 37ЊC. The MIC was recorded after 20 h.
Bioluminescence assay of ATP. (i) Analytical equipment. Light emission from the bioluminescence assay was measured in a 1250 Luminometer (LKB-Wallac, Turku, Finland) and was recorded on a 1250 Display (LKB-Wallac). The extraction of intracellular bacterial ATP was performed in a LKB-Biocal 2073 incubator (LKB Products, Bromma, Sweden).
(ii) Analytical reagents. ATP-monitoring reagent (Bio Orbit, Turku, Finland) was used in the assay for ATP. Apyrase (purified grade I; Sigma Chemical Co.) was used to eliminate extracellular ATP before the extraction of intracellular ATP. Other reagents were of analytical grade.
(iii) Elimination of extracellular ATP. A 100-l sample from the culture was incubated for 10 min at 37ЊC with 100 l of solution consisting of 0.04% apyrase in supplemented MHB for growing cultures and in PBS for nongrowing cultures.
(iv) Extraction of intracellular ATP. After elimination of extracellular ATP, 50 l of the apyrase-treated sample was pipetted into 500 l of boiling 0.1 M Tris buffer (pH 7.75) containing 2 mM EDTA. After being heated for 90 s, the extracts were cooled before the assay of ATP. This procedure inactivated the apyrase and disrupted the bacterial cells, causing them to release their ATP.
(v) Luciferase assay of ATP. Luciferase reagent (100 l) was added to 550 l of each extract, and the light intensity was recorded.
(vi) Calculation of assay results. Sample ATP levels were calculated by using assays of standard amounts of ATP as a reference. Correction was made for background luminescence. The 11-fold dilution of the sample during the extraction of intracellular ATP prevented the inhibition of the luciferase reaction by the extracts. This was verified through the addition of known amounts of ATP to the extracts.
Determination of PAE and CERT. The ATP levels in the cultures were determined immediately before and at the end of the 2-h antibiotic exposure. In order to eliminate the antibiotics, all cultures were then diluted 1,000-fold with prewarmed MHB. Regrowth in the diluted culture was monitored each hour by the bioluminescence assay of bacterial ATP. The PAE was calculated from the regrowth curves by the equation PAE ϭ T PAE Ϫ C PAE , where T PAE is the time required for the bacterial population in the test culture to increase by 1,000-fold after elimination of the drug, and C PAE is the corresponding time for the control culture ( Fig. 2A) . The ATP levels in the drug-exposed cultures immediately after 1,000-fold dilution were below the detection limit. Therefore, the ATP was measured before dilution, and the values obtained (divided by 1,000) were used as the starting values in these calculations ( Fig. 2A) . Normally, the PAE is calculated on the basis of the time taken for the bacterial numbers to increase 10-fold. Since the ATP concentrations after a 1,000-fold dilution of drug-exposed culture were below the detection limit, we chose to use the time taken for bacterial numbers to increase 1,000-fold, which we considered adequate, since the growth curves for drug-treated and untreated bacteria were parallel once the growth had started ( Fig. 2A) (8) .
The CERT was also calculated from the growth curves by the equation CERT ϭ T CERT Ϫ C CERT , where T CERT is the time required for the bacterial population in the test culture to resume logarithmic growth and return to the preexposure inoculum after drug exposure and elimination of drug by 1,000-fold dilution of the culture, and C CERT is the corresponding time for the control culture (9, 10) . Definition of synergism. The drugs were combined at multiples of the MICs of the single drugs. The PAE induced by the combined drugs was defined as synergistic when the mean PAE of the drug combination was longer than the sum of the mean PAE of the single drugs (i.e., PAE AϩB Ͼ PAE A ϩ PAE B ) (11). Synergy measured with CERT was defined correspondingly. Cultures in which synergism was shown according to the definition given above were statistically evaluated by two-tailed paired t test.
RESULTS

MICs.
The MICs of amikacin, imipenem, ofloxacin, rifampin, and vancomycin for S. epidermidis ATCC 35984 were 8, 4, 1, 0.03, and 2 g/ml, respectively.
Growing bacteria exposed to antibiotics. All drugs induced a concentration-dependent PAE and CERT in the MHB cul- 
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tures. However, rifampin reached almost its maximum effect at 0.06 g/ml (2ϫ the MIC) ( Table 2 ; Fig. 3 ). The lengths of PAE and CERT in the growing cultures were as follows: ofloxacin Ͼ rifampin Ͼ amikacin Ͼ vancomycin Ͼ imipenem for S. epidermidis (Table 1 ; Fig. 3 ). CERT was generally longer than PAE for all drugs except ofloxacin (Table 1 ; Fig. 3 ). This difference was observed when the initial change in intracellular ATP was prominent. Nongrowing bacteria exposed to antibiotics. PAE or CERT exceeding 1 h was induced by rifampin at concentrations above 0.03 g/ml (1ϫ the MIC) and by ofloxacin at 16 g/ml (16ϫ the MIC) for nongrowing cultures (Table 1; Fig. 3) .
Growing bacteria exposed to antibiotic combinations. When the MHB cultures were exposed to combinations of drugs, the PAE and CERT of most of the combinations were in the same range as those for the single drugs (Tables 1 and 2 ; Fig. 3 and  4) . When imipenem was combined with either amikacin or vancomycin, they were synergistic at all concentrations, as determined by PAE and CERT (Table 2) . When the other drugs were combined, they induced no synergistic effect against S. epidermidis, as determined by PAE or CERT or induced a synergistic effect only at low concentrations (Table 2) .
Nongrowing bacteria exposed to antibiotic combinations. No drug combination was synergistic against nongrowing bacteria. However, rifampin combined with other drugs gave stronger effects than the other drug combinations against nongrowing bacteria, especially when rifampin was combined with ofloxacin.
DISCUSSION
Rifampin was the only drug that induced strong pharmacodynamic effects (PAE and CERT) against both growing and nongrowing S. epidermidis, while amikacin, ofloxacin, imipenem, and vancomycin were only effective against growing S. epidermidis ( Fig. 3 and Table 1 ). PAE describes the delayed regrowth after drug removal, and CERT describes the combined effects of an initial change in bacterial density during drug exposure and delayed regrowth after drug removal (9) . The length of the PAE is dependent on the method used for bacterial quantitation, since the starting point is calculated from the number of cells just after or at the end of a brief antibiotic exposure (Fig. 2B) , and these estimations of bacterial density vary with the method used (9, 10, 13) . In a previous report, we have shown that CERT can circumvent this methodological problem since CERT is calculated from the preexposure inoculum and is therefore independent of the methods used for bacterial quantitation (9) .
It is claimed that imipenem kills nongrowing gram-negative bacteria (16) . However, this is only true when the culture is prestarved for 45 min or less (16) . In this study imipenem at 32 g/ml (8ϫ the MIC) induced a maximum PAE and CERT of 1.8 and 2.8 h, respectively, (Table 1; Fig. 3 ) against the growing culture of oxacillin-resistant S. epidermidis. In the nongrowing cultures, imipenem induced neither PAE nor CERT (Table 1 ; Fig. 3) .
Vancomycin is often used to treat multidrug-resistant S. epidermidis isolates, which are often found on the surfaces of biomaterials. In this study, vancomycin induced pharmacodynamic effects only against growing cultures, which is in agreement with a time-kill study by Widmer et al. (17) with growing and nongrowing S. epidermidis cells. In the growing S. epidermidis cultures, imipenem combined with vancomycin induced a synergistic effect, as determined by PAE and CERT (Tables 1  and 2 ). This synergy was stronger at lower antibiotic concentrations (Tables 1 and 2 ) and may be caused by interference by these drugs at different stages of cell wall synthesis.
Amikacin, which inhibits the formation of polypeptides through binding to the ribosome, induced pharmacodynamic effects against growing but not nongrowing cultures ( Fig. 3 ; Table 1 ). A similar loss of effect was also seen in a study by Eng et al. (7) with nongrowing S. aureus exposed to gentamicin for FIG. 3 . PAE (t, s) and CERT (E, F) for growing (t, E) and nongrowing (s, F) cultures of S. epidermidis ATCC 35984 exposed to single drugs. Concentrations in micrograms per milliliter are given in Table 1 .
FIG. 4. PAE (t, s)
and CERT (E, F) for growing (t, E) and nongrowing (s, F) cultures of S. epidermidis ATCC 35984 exposed to combinations of drugs at multiples of the MICs of the single drugs. Concentrations in micrograms per milliliter are given in Table 1. 24 h. Amikacin combined with imipenem induced synergy in our study, but only against growing cultures (Table 2) . By other methods, in vitro drug synergism has been demonstrated against growing gram-positive cocci exposed to combinations of ␤-lactam antibiotics with aminoglycosides, rifampin, or glycopeptides (6) . None of the combinations that induced a synergistic effect against growing S. epidermidis, as determined by PAE and CERT, induced a synergistic effect against the nongrowing cultures.
The only drug that had a strong effect against nongrowing bacteria was rifampin, which affects the synthesis of mRNA. Rifampin induced a maximum PAE and CERT of 8.0 and 5.6 h, respectively, against growing S. epidermidis cultures and 3.6 and 3.5 h, respectively, against nongrowing cultures ( Fig. 3 ; Table 1 ). Similar to the results of our study ( Fig. 3; Table 1 ), time-kill curves for nongrowing S. epidermidis cultures exposed to rifampin were almost equal to those obtained for logarithmically growing bacteria (17) . Studies on the metabolism of marine Vibrio species have indicated that protein synthesis is essential for the survival of starving vibrios (12, 14) . Rifampin remained equally as bactericidal against marine Vibrio cultures starved for 24 h as against logarithmically growing cultures (2). Furthermore, it was also shown that the residual protein synthesis decreases, but does not cease, during 24 h of starvation of vibrios (2), and there is a synthesis of new mRNAs with long half-lives coding for new proteins essential for recovery from starvation (1) . This may explain the remaining effects of rifampin against nongrowing staphylococci in our study (Fig. 3 ) and in the study by Widmer et al. (17) .
A low level of DNA replication may explain why, in our study, ofloxacin maintained some of its pharmacodynamic effects against nongrowing cultures. Against nongrowing cultures, ofloxacin combined with rifampin induced the strongest PAE and CERT, but they were not synergistic either against growing or nongrowing cultures, as determined by PAE or CERT.
In conclusion, this study indicates that rifampin is the only drug tested that has strong pharmacodynamic effects (PAE and CERT) against growing as well as nongrowing S. epidermidis cultures. All other drugs tested induced prominent PAEs and CERTs only against growing cultures. A synergistic effect was induced when imipenem was combined with amikacin or vancomycin against growing S. epidermidis cultures, but no combination induced a synergistic effect against nongrowing cultures. When rifampin was combined with other antibiotics, the pharmacodynamic effects were mainly from the effect of rifampin.
